Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.01 from other evidence | 0.00 |
| cell type Human Protein Atlas | enriched in the midbrain (64 nTPM), where the nigral dopamine neurons sit | 0.90 |
| chemistry Open Targets | reachable by antibody | 0.36 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | no papers tie it to Parkinson's yet | 1.00 |
| pathways Reactome | 2 pathways; mostly other | 0.30 |
No case: the score is under the bar. Receipt 9714
Sealed predictions
- NPNT in dopamine neurons, braak+0.15 (p 0.699) → +0.54 (p 0.130)receipt 9721
Swarm cases
receipt 9721: NPNT in dopamine neurons, braak
- power
- full sample +0.32 (p 0.191, n 18), 95% CI -0.17 to +0.69. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.32 (p 0.191, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.30 (p 0.225, n 18). could be the mix.
- skeptic
- leave-one-out range +0.23 to +0.44, sign flips 0; without severely affected donors +0.32 (p 0.191, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for NPNT in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts